Kleresca® Clinical Results
Individual results may vary.
Visit www.Kleresca.com to see additional patient experiences and find a clinic near you.
“It has been challenging living with acne. I just wanted to hide myself in all pictures. Things have completely changed since then. The scarring in my face is completely gone. I forgot to wear make-up to
More than 9 out of 10 patients benefitted from at least 1 IGA* grade improvement of their acne compared to 73% in the control (standard of care) at week (6) six1
There was a reduction of at least 40% in inflammatory acne lesion counts in 82% of patients compared to 46% in the control group at week 121
More than half of patients benefited from at least 2 IGA* grade improvements of their acne compared to 18% in the control group at week 121
92% of patients who benefitted from at least 2 IGA* grade improvements of their acne maintained their gains at week 242
Excellent compliance rate throughout lengthy 24-week long study period in young patient population (mean age: 22 years)2
Kleresca® Skin Rejuvenation is a gentle, effective, and non-destructive treatment that uses fluorescent light energy (FLE) to stimulate the skin’s own rejuvenation process. Scientifically proven, this treatment improves the complexion and overall skin texture without causing any trauma:
• Induces collagen production up to 400%
• Slows down signs of skin ageing
• Improves pore size, fine lines, and skin texture
• Suitable all year round, including summer
The difference is fluorescent
The innovation of the Kleresca® Skin Rejuvenation system lies in its ability to create fluorescent light energy (FLE) that activates the skin’s collagen production cells (fibroblasts). With a collagen boost of up to 400%, it leaves your skin revitalised, firm, and glowing. Studies show Kleresca® Skin Rejuvenation induces an approximate 400% increase in collagen production.
Kleresca® Safety Profile
Kleresca® Treatments are not absorbed or metabolized by the skin and are considered to be a pleasant and comfortable experience by patients.
In clinical trials, Kleresca® showed high safety with no serious adverse events.
All side effects were transient, nonpermanent and did not require any intervention by the clinic.